Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19

High levels of autoimmune antibodies are observed in COVID-19 patients but their specific contribution to disease severity and clinical manifestations remains poorly understood. We performed a retrospective study of 115 COVID-19 hospitalized patients with different degrees of severity to analyze the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Claudia, Zuniga, Marisol, Crotty, Kelly A, Qian, Kun, Tovar, Nubia Catalina, Lin, Lawrence Hsu, Argyropoulos, Kimon V, Clancy, Robert, Izmirly, Peter, Buyon, Jill, Lee, David C, Yasnot-Acosta, Maria Fernanda, Li, Huilin, Cotzia, Paolo, Rodriguez, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441539/
https://www.ncbi.nlm.nih.gov/pubmed/34504035
http://dx.doi.org/10.26508/lsa.202101180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441539/
https://www.ncbi.nlm.nih.gov/pubmed/34504035
http://dx.doi.org/10.26508/lsa.202101180

Ejemplares similares